<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="62258">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02144636</url>
  </required_header>
  <id_info>
    <org_study_id>herbalife.2014</org_study_id>
    <nct_id>NCT02144636</nct_id>
  </id_info>
  <brief_title>Protein Supplementation and Weight Loss</brief_title>
  <official_title>Effect of Protein Supplementation on Weight Loss and Cardio Metabolic Profile of Overweight/Obese Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diabetes Foundation, India</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diabetes Foundation, India</source>
  <oversight_info>
    <authority>India: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized control trial  of  diet with protein supplementation is being conducted to
      test the hypothesis that in overweight/obese subjects high protein diet may lead to weight
      loss and improvement in cardio-metabolic profile.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>weight loss</measure>
    <time_frame>baseline to 3 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>improvement in lipid profile</measure>
    <time_frame>baseline - 3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>treament</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>herbalife protein shake along with exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>diet and exercise only</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>herbalife protein shake</intervention_name>
    <arm_group_label>treament</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects aged between 21 -65 years

          2. Subjects with BMI &gt; 23 Kg/m2

        Exclusion Criteria:

          -  Inclusion Criteria:

               1. Subjects aged between 21 -65 years

               2. Subjects with BMI &gt; 23 Kg/m2

        Exclusion Criteria:

          1. Diabetes (type 1 and type 2)

          2. Known or documented coronary heart disease (CHD) (including ECG consistent with prior
             myocardial infraction), cerebrovascular accident (including transient ischemic
             attack), peripheral vascular disease (including symptoms of claudication)

          3. Angina or other chest pain that may indicate CHD by history

          4. Clinically significant neoplastic, cardiovascular, hepatic, renal, metabolic,
             endocrine (untreated or unstable), or psychiatric (untreated or unstable) by history

          5. Medications: Lipid lowering therapy, daily NSAID or greater than 325 mg ASA (PRN use
             ok), clopidogrel (or equivalent), Coumadin, other investigational drugs within 30
             days of study entry

          6. Pregnancy or planning pregnancy during the study period by history

          7. Uncontrolled hypertension

          8. Uncontrolled hypothyroidism

          9. Sensitivity or allergy to product by history

         10. Subjects who had undergone bypass procedure

         11. Any debilitating disease such as tuberculosis, HIV by history .

         12. Unwillingness to give written informed consent for participation in the study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anoop Misra, MD</last_name>
    <phone>49101222</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology</name>
      <address>
        <city>Delhi</city>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anoop Misra, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 20, 2014</lastchanged_date>
  <firstreceived_date>May 20, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Diabetes Foundation, India</investigator_affiliation>
    <investigator_full_name>Dr Anoop Misra</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
